Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
$2.99M Sell
45,698
-2,173
-5% -$137K 0.6% 42
2014
Q3
$2.77M Sell
47,871
-2,317
-5% -$129K 0.52% 49
2014
Q2
$2.83M Sell
50,188
-2,715
-5% -$142K 0.54% 51
2014
Q1
$2.72M Sell
52,903
-3,768
-7% -$190K 0.5% 53
2013
Q4
$2.99M Sell
56,671
-9,142
-14% -$449K 0.54% 51
2013
Q3
$2.94M Buy
65,813
+12,301
+23% +$545K 0.52% 53
2013
Q2
$2.21M Buy
+53,512
New +$2.34M 0.46% 54

Other funds holding ABBV

Robert N. Shapiro's ABBV Position: Q4 2014 in Review

Robert N. Shapiro reduced its AbbVie (ABBV) stake by 4.5% in Q4 2014, selling an estimated $137K and leaving 45,698 shares worth $2.99M. The position accounts for 0.6% of the portfolio, ranked #42.

Robert N. Shapiro first reported a position in ABBV in Q2 2013 and has held it in 7 quarters since. The position peaked at $2.99M in Q4 2013. 1,606 funds tracked by Wall St. Rank hold ABBV as of Q4 2014.

  • Robert N. Shapiro held 45,698 shares of AbbVie worth $2.99M as of Q4 2014.
  • Robert N. Shapiro sold 2,173 AbbVie shares in Q4 2014, an estimated $137K.
  • AbbVie made up 0.6% of Robert N. Shapiro's portfolio in Q4 2014, its #42 holding.
  • Robert N. Shapiro first reported a position in AbbVie in Q2 2013 and has held it in 7 quarters since.
  • Robert N. Shapiro's AbbVie position peaked at $2.99M in Q4 2013.
  • 1,606 funds tracked by Wall St. Rank held AbbVie as of Q4 2014.

Based on Robert N. Shapiro's 13F filing for Q4 2014, filed 19 Feb 2015.